AsedaSciences – Talk Bio

Actionable Insights Powered by AI

AsedaSciences and Clyde Biosciences Announce Commercial Agreement to Integrate Human-Relevant Cardiotoxicity Screening

1 day ago talkbio0Tagged AsedaSciences, cardiotoxicity screening, CellOPTIQ, Clyde Biosciences, NAMs, New Approach Methods, Platform

AsedaSciences; Clyde Biosciences; 3RnD platform; CellOPTIQ; cardiotoxicity screening; New Approach Methods; NAMs

AsedaSciences and GenEvolutioN Announce Sales & Marketing Agreement to Integrate Genotoxicity Screen into 3RnD Platform

1 day ago talkbio0Tagged Agreement, AsedaSciences, GenEvolutioN, genotoxicity, NAMs, New Approach Methods, Sales - occupational activity, Screens (device)

AsedaSciences; GenEvolutioN; 3RnD; genotoxicity screen; sales agreement; New Approach Methods; NAMs